A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning ...

Trump had maintained that he received an MRI in October. For weeks, President Donald Trump has said that he received an MRI at Walter Reed National Military Medical Center in October, but when asked ...

The following content is brought to you by Mashable partners. If you buy a product featured here, we may earn an affiliate commission or other compensation. No home office? No problem. Gone are the ...

At PCMag, my focus is on printers and scanners. I started out way back in 1988 at Compute!, which still had a section of the magazine devoted to type-in programs. Since then, I’ve written more than ...

It’s 11 a.m. on a Monday and I’m in my underwear, standing inside a sci-fi-like version of an airport security scanner. This is my first body scan. I’m about to have my insides documented in a process ...

When addressing the serious concern of colon cancer, many people wonder about the effectiveness of standard imaging tools like the CT (Computed Tomography) scan. The direct answer is yes, a CT scan ...

Great. Well, thank you, everyone, for joining our fireside chat with Telix. My name is David Dai. I'm one of the biotech analysts here at UBS. [Operator Instructions] In the meantime, I'd love to ...

President Trump’s off-the-cuff disclosure that he underwent an MRI scan is raising fresh questions about the secrecy surrounding Trump’s health and the need for presidents to be more transparent.

Pendergrast is an anesthesiology resident physician at the University of Michigan. The 1 in 5 Americans suffering from chronic pain may soon lose access to evidence-based interventions that have ...

SCAN Health Plan is teaming up with big-box retailer Costco to offer members notable cost savings on medications, key vaccinations and other over-the-counter essentials. Costco will become a preferred ...

Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...